BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang IH, Jung JY, Kim SH, Yoo ES, Cho NP, Lee H, Lee JY, Hong SD, Shin JA, Cho SD. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein. Cell Oncol (Dordr) 2019;42:357-68. [PMID: 30919222 DOI: 10.1007/s13402-019-00431-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Ahn CH, Lee WW, Jung YC, Shin JA, Hong KO, Choi S, Swarup N, Kim J, Ahn MH, Jung M, Cho SD, Jin B. Antitumor effect of TW-37, a BH3 mimetic in human oral cancer. Lab Anim Res 2019;35:27. [PMID: 32257914 DOI: 10.1186/s42826-019-0028-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mohamad Anuar NN, Nor Hisam NS, Liew SL, Ugusman A. Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent. Front Pharmacol 2020;11:564108. [PMID: 33381025 DOI: 10.3389/fphar.2020.564108] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Yeo SG, Lee SJ, Lee JW, Oh S, Park DC. Levels of endoplasmic reticulum stress-related mRNA in peritoneal fluid of patients with endometriosis or gynaecological cancer. J Int Med Res 2021;49:3000605211065376. [PMID: 34904478 DOI: 10.1177/03000605211065376] [Reference Citation Analysis]
4 Melo G, Silva CAB, Hague A, Parkinson EK, Rivero ERC. Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge. Oral Oncol 2022;132:105979. [PMID: 35816876 DOI: 10.1016/j.oraloncology.2022.105979] [Reference Citation Analysis]
5 Yu R, Lu Y, Yu R, Xie J, Zhou S. Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells. Cancer Manag Res 2021;13:953-63. [PMID: 33568941 DOI: 10.2147/CMAR.S265788] [Reference Citation Analysis]
6 Pan Y, Zhao S, Chen F. The potential value of dequalinium chloride in the treatment of cancer: Focus on malignant glioma. Clin Exp Pharmacol Physiol 2021;48:445-54. [PMID: 33496065 DOI: 10.1111/1440-1681.13466] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nor Hisam NS, Ugusman A, Rajab NF, Ahmad MF, Fenech M, Liew SL, Mohamad Anuar NN. Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence. Pharmaceutics 2021;13:1353. [PMID: 34575429 DOI: 10.3390/pharmaceutics13091353] [Reference Citation Analysis]
8 Liao Q, Gao X. Tribbles homolog 3 contributes to high glucose-induced injury in retinal pigment epithelial cells via binding to growth factor receptor-bound 2. Bioengineered 2022;13:10386-98. [DOI: 10.1080/21655979.2022.2056315] [Reference Citation Analysis]
9 Xu J, Wu Z, Huang J. Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1. Drug Des Devel Ther 2021;15:1705-16. [PMID: 33935493 DOI: 10.2147/DDDT.S284213] [Reference Citation Analysis]
10 V B, Femina T A, Iyengar D, K A, Ravi M. Approaches for Head and Neck Cancer Research - Current Status and the Way Forward. Cancer Invest 2021;:1-22. [PMID: 34806936 DOI: 10.1080/07357907.2021.2009850] [Reference Citation Analysis]